A Carrier of Duchenne Muscular Dystrophy in an 8-month-old Girl
2
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Duchenne muscular dystrophy (DMD) is the most common and severe form of childhood muscular dystrophy. Females are affected in rare cases because of its’ X- linked, recessive inheritance. A small number of female DMD carriers have muscle weakness to some extent. A healthy 8-month-old girl was brought to our tertiary center because of the elevated serum liver enzyme (aspartate aminotransferase (AST): 986 IU/mL, alanine aminotransferase (ALT): 1,126 IU/mL), that was first noted 1 month ago when she was hospitalized for an acute respiratory infection. Follow-up her serum liver enzyme, AST and ALT level remained increased to 613 and 1,049 IU/mL, respectively without serologic evidence of viral hepatitis. Serum creatinine kinase (CK) level was highly elevated to 5,245 U/L. She showed normal development. Pseudohypertrophy of bilateral calf muscle was not observed, and Gowers’ sign was not seen because of her young age. Electromyography and cardiac echocardiography showed no abnormal findings. A multiplex ligation-dependent probe amplification confirmed the heterozygote deletion mutation of DMD gene in exon 10-17. The result of karyotyping was normal 46,XX. She was diagnosed as an asymptomatic DMD carrier. Female carriers are usually asymptomatic but may have an elevated serum CK and/ or mild calf hypertrophy. A girl with persistent elevated liver enzyme and CK level should be evaluated for the neuromuscular disease including DMD, despite her normal motor activity.
Abstract
Duchenne muscular dystrophy (DMD) is the most common and severe form of childhood muscular dystrophy. Females are affected in rare cases because of its’ X- linked, recessive inheritance. A small number of female DMD carriers have muscle weakness to some extent. A healthy 8-month-old girl was brought to our tertiary center because of the elevated serum liver enzyme (aspartate aminotransferase (AST): 986 IU/mL, alanine aminotransferase (ALT): 1,126 IU/mL), that was first noted 1 month ago when she was hospitalized for an acute respiratory infection. Follow-up her serum liver enzyme, AST and ALT level remained increased to 613 and 1,049 IU/mL, respectively without serologic evidence of viral hepatitis. Serum creatinine kinase (CK) level was highly elevated to 5,245 U/L. She showed normal development. Pseudohypertrophy of bilateral calf muscle was not observed, and Gowers’ sign was not seen because of her young age. Electromyography and cardiac echocardiography showed no abnormal findings. A multiplex ligation-dependent probe amplification confirmed the heterozygote deletion mutation of DMD gene in exon 10-17. The result of karyotyping was normal 46,XX. She was diagnosed as an asymptomatic DMD carrier. Female carriers are usually asymptomatic but may have an elevated serum CK and/ or mild calf hypertrophy. A girl with persistent elevated liver enzyme and CK level should be evaluated for the neuromuscular disease including DMD, despite her normal motor activity.
참고문헌 (19)
- Ou Z, "Duchenne muscular dystrophy in a female patient with a karyotype of 46, X, i(X)(q10)", Tohoku J Exp Med, 222, pp.149~153 (2010)
- Hoogerwaard EM, "Signs and symptoms of duchenne muscular dystrophy and becker muscular dystrophy among carriers in the netherlands : A cohort study", Lancet, 353, pp.2116~2119 (1999)
- Emery AE, "The muscular dystrophies", Lancet, 359, pp.687~695 (2002)
- 송태진, "Three Cases of Manifesting Female Carriers in Patients with Duchenne Muscular Dystrophy", Yonsei Medical Journal, 52(1), pp.192~195 (2011), 연세대학교의과대학
- 윤지열, "Carrier Woman of Duchenne Muscular Dystrophy Mimicking Inflammatory Myositis", Journal of Korean Medical Science, 26(4), pp.587~591 (2011), 대한의학회
- 양명석, "터너 증후군 여아에서 발생한 뒤시엔느형 근 디스트로피-증례 보고-", Annals of Rehabilitation Medicine, 29(5), pp.537~540 (2005), 대한재활의학회
- Lee KA, "Becker muscular dystrophy with r(X)carrying an out-of-frame DMD deletion", Pediatr Neurol, 39, pp.129~132 (2008)
- Bonilla E, "Normal and dystrophin-deficient muscle fibers in carriers of the gene for duchenne muscular dystrophy", Am J Pathol, 133, pp.440~445 (1988)
- Yoshioka M, "Skewed X inactivation in manifesting carriers of duchenne muscular dystrophy", Clin Genet, 53, pp.102~107 (1998)
- Schanzer A, "Duchenne muscular dystrophy in a 4-year-old girl due to heterozygous frame shift deletion of the dystrophin gene and skewed Xinactivation", Klin Padiatr, 224, pp.256~258 (2012)
- Soltanzadeh P, "Clinical and genetic characterization of manifesting carriers of DMD mutations", Neuromuscul Disord, 20, pp.499~504 (2010)
- Katayama Y, "Co-occurrence of mutations in both dystrophin-and androgenreceptor genes is a novel cause of female duchenne muscular dystrophy", Hum Genet, 119, pp.516~519 (2006)
- van Essen AJ, "Detection of point mutation in dystrophin gene reveals somatic and germline mosaicism in the mother of a patient with duchenne muscular dystrophy", Am J Med Genet A, 118, pp.296~298 (2003)
- Seemann N, "9 year old girl with progressive weakness", Brain Pathol, 20, pp.255~256 (2010)
- Griggs RC, "Clinical investigation in duchenne dystrophy: V. use of creatine kinase and pyruvate kinase in carrier detection", Muscle Nerve, 8, pp.60~67 (1985)
- Beggs AH, "Detection of 98% of DMD", BMD gene deletions by polymerase chain reaction, 1990, pp.86, 45~48
- Schwartz M, "Multiplex ligation-dependent probe amplification is superior for detecting deletions", duplications in duchenne muscular dystrophy, 2005, pp.67, 189~191
- Nolan MA, "Cardiac assessment in childhood carriers of duchenne and becker muscular dystrophies", Neuromuscul Disord, 13, pp.129~132 (2003)
- Lukasik E, "Electrocardiographic studies in female carriers of duchenne muscular dystrophy", J Neurol, 209, pp.279~285 (1975)